Focus: Dexcom is a leader in continuous glucose monitoring (CGM) technology for diabetes management, headquartered in San Diego and founded in 1999. The company operates in the metabolic diseases segment with a focused, specialized product portfolio.
Profile data last refreshed 8h ago · AI intelligence enriched 2mo ago
Hot — 517 jobs added in 30d
Net +457 (517 new, 60 removed). Aggressive expansion phase.
Dexcom offers stable, specialized biotech career growth in a dominant market position, best suited for professionals seeking deep expertise in diabetes care rather than broad pharma exposure.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship product with expanding market penetration and recurring user base; primary revenue driver.
Help build intelligence for Dexcom
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Dexcom's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo